Imagine a future where the moment you’re born, a virtual avatar is created and steadily filled with personalised information ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

Dr. Uwais Zaid of OSF HealthCare highlights the importance of early prostate cancer screening and risk factors, especially ...

Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...

Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...

Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease.

September is Prostate Cancer Awareness Month, and for millions of men across the country, it's is a crucial reminder about the importance of early detection ... It's typically found through a blood ...

There is widespread misinformation when it comes to prostate cancer. Oncologist Dr Sudipto De debunks 4 myths and stresses the importance of regular screenings.

Former President Joe Biden's diagnosis with an advanced stage of prostate cancer that has metastasized, or spread, to his bones prompted an outpouring of concern and questions about his condition.

Share on Pinterest Scientists are working on developing a urine test to detect prostate cancer. Anchalee Phanmaha/Getty Images Early detection of prostate cancer remains a major clinical challenge due ...